Neurovalens

Insomnia Relief with Neurostimulator Device – Modius Sleep

United Kingdom · $6.3M raised

Business Model
B2B
Total Funding
$6.3M
Last Round
$6.3M Series AMar 2019
Rounds
1

About

Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world's greatest health challenges. It uses neurostimulation therapy to address chronic insomnia and anxiety non-invasively. After a study of Modius Sleep for chronic insomnia, the company received FDA 510(k) clearance in October 2023, then FDA clearance for Modius Calm for anxiety in March 2024, with later FDA and EU/UK approvals for additional Modius devices including weight-management and PTSD indications. Modius is exclusively available to veterans through the U.S. Department of Veterans Affairs.

Summary

Neurovalens is a Healthcare company based in United Kingdom. It has raised $6.3M in total across 1 round, most recently a $6.3M Series A round in Mar 2019.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2019
$6.3M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurovalens on Indexed.vc
<a href="https://indexed.vc/companies/neurovalens"><img src="https://indexed.vc/api/badge/company/neurovalens" alt="Neurovalens on Indexed.vc" width="260" height="76" /></a>